This outcome appeared to be quite specific, given that this study did not observe any significant expression changes in other IAP family members (IAP-1, survivin, or Bruce) through the modulation of RASSF1A expression (Figure 2) despite the fact that survivin expression has been previously reported to be increased in RASSF1A-depleted SKOV-3 ovarian cancer cells [46]. The gene discussed is RASSF1; the disease is ovarian carcinoma.